WESTERN MARKET RESEARCH(WMR) has come up with syndicate market research report on-The Tumor Ablation market was valued at USD 973.4 million in 2018 and is predicted to grow at a CAGR of 11.2%, with forecasts for 2026 eclipsing USD 2.30 billion.
|Tumor Ablation Market Size, Share & Trends Analysis Report By Treatment (Surgical, Percutaneous, Laparoscopic), By Technology (Cryoablation, IRE, MWA, RFA), By Application (Liver, Lung, Breast, Prostate) and Region, Forecasts to 2026|
|Ask for Sample/Enquiry and details report @ WMR|
|https://westernmarketresearch.com/product-details.php?pid=339954&Tumor Ablation Market Size, Share & Tren#sample|
|WMR-Western Market Research has recently published a comprehensive and exclusive research report, which is an intelligent study covering all key segments. This research report provides breakthrough inputs and insights on market related factors like size, competition, trends, analysis, forecasts etc. The study encompasses primary and secondary data sources along with quantitative and qualitative practices thus assuring data accuracy.|
|The Tumor Ablation market was valued at USD 973.4 million in 2018 and is predicted to grow at a CAGR of 11.2%, with forecasts for 2026 eclipsing USD 2.30 billion. The market is driven by growing incidence of chronic target diseases like cancer, coupled with the increasing efficiency and effectiveness of tumor ablation, increasing demand for noninvasive procedures, and technological advancements in tumor ablation equipment. The economic impact of cancer is increasing which is the result of increased cancer prevalence among population and which will boost the requirements of the cancer treatment. The total annual cost in year 2010 was approximately USD 1.16 trillion. Since tumor ablation is yet to be tested for a wide range of diseases and applications, unexplored medical conditions gives opportunities for the market to grow. Furthermore, increasing public awareness programs and funds provided by government of various countries for cancer research, is expected to propel the market.
Tumor ablation is therapy that uses an array of parallel alternating electrodes to deliver radiofrequency energy that heats the lining of the gastrointestinal tract, destroying the cancerous or infected tissue. Tumor ablation has primarily been used for the treatment of esophageal squamous cell dysplasia, gastric antral vascular ectasia, radiation proctopathy, cholangiocarcinoma, and pancreatic neoplasia. Ablation is preferred over other methods of treatment of cancer such as conventional surgery due to multiple advantages like no skin incision minimal risk to patient, little to no pain inflicted and a short duration of hospital stay. Recent technological advancements in technologies being used in ablation such as multiple electrode Radio Frequency System which uses multichannel Radiofrequency generator which works on no-touch mechanism resulting in low Local Tumor Progression. Introduction of new products in the market such as Circumferential ablation catheters, Focal ablation catheters and the Barrx Flex energy generator has made it possible for patients to receive extremely effective treatment without any unnecessary damage. However, associated side effects like inflammation of the gallbladder, biliary obstruction due to bile duct damage, thermal mutilation of the bowels and flu-like symptoms, exorbitant cost of tumor ablation techniques, and restrictions in the volume of tumors that can be removed is deterring the growth of the global tumor ablation market. Although the cost of treatment is inexpensive, the cost of RFA machines are quite high since they have only been recently developed and are still undergoing research. According to regional segmentation North America especially US experienced approximately 1,735,350 new cases of cancer in the year 2018 with having more number of cancer deaths as well as higher cancer cases in men than in women. As of today there are only 52 centres around the world that provide RFA treatments.
Click for BUY NOW and ask for lucrative Discount @ WMR
The global Tumor Ablation market has been segmented on the basis of product type, device type, and application. The research takes a closer look at prominent driving factors responsible for the 8.1% CAGR. The study also analyses the market share of each region, company and product. The report also presents constraints, opportunities, threats, challenges and Investment opportunities prevailing in the market.Galil Medical, Inc.; Misonix, Inc.; HealthTronics; Boston Scientific Corporation; Medtronic Plc; SonaCare Medical; EDAP TMS S.A.; and Neuwave Medical, Inc. are dominating players in the market and are the companies considered for this report.Surgical, Percutaneous, Laparoscopic,Cryoablation, IRE, MWA, RFA,Liver, Lung, Breast, Prostate
|Click to know more about product @ WMR|
|https://westernmarketresearch.com/product-details.php?pid=339954&Tumor Ablation Market Size, Share & Tren#description|